Arun Chauhan

Arun Chauhan currently serves as Scientist II at Precigen, focusing on the development of AdenoVerse gene therapies aimed at addressing immune-oncology and infectious diseases, including HPV and HBV+ cancers. Previously, Arun worked as an Assistant Research Professor at the University of North Dakota, where mentoring and research on Sepsis co-infection mice models were central to the role, emphasizing immunological, molecular biology, and epigenetic studies. Arun holds a Doctor of Philosophy from Aligarh Muslim University, investigating the potential of Escheriosome-mediated cytosolic delivery for enhancing T lymphocyte responses. Additionally, Arun contributed as a Project Specialist at the Institute of Microbial Technology, exploring the effects of Caerulomycin A on T-cell suppression. Educational qualifications include a Master's degree in Microbiology and Immunology from Earthinators Climate School and a Bachelor's degree in Zoology/Animal Biology from Maharshi Dayanand University.